BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20230312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20231105T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240627T130000
DTEND;TZID=America/Halifax:20240627T140000
DTSTAMP:20260611T153950
CREATED:20240610T163717Z
LAST-MODIFIED:20241024T183045Z
UID:10000769-1719493200-1719496800@staging.digitalinsights.supremeclients.com
SUMMARY:Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
DESCRIPTION:Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand\, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes\, targeted NGS is not only a cost-effective solution\, but can rapidly deliver insights into a tumor molecular profile. \nTo address this challenge\, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels\, named “Glioma” and “Routine Diagnostics”\, targeting single nucleotide variations\, insertions/deletions\, fusions\, and copy number variations of tumor-associated essential genes. \nIn this webinar\, attendees will:\nUnderstand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis\nLearn about the design and application of these NGS panels\nGain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/benefits-of-integrating-targeted-next-generation-sequencing-ngs-panels-into-molecular-diagnostics-of-solid-tumors/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1314_3_QDI_QCI_SampletoInsight_Oncology_GI1388388119.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240627T130000
DTEND;TZID=America/Halifax:20240627T140000
DTSTAMP:20260611T153950
CREATED:20240808T095718Z
LAST-MODIFIED:20241024T182402Z
UID:10000561-1719493200-1719496800@staging.digitalinsights.supremeclients.com
SUMMARY:Benefits of integrating targeted next-generation sequencing (NGS) panels into molecular diagnostics of solid tumors
DESCRIPTION:Variant detection of multiple genes from a single tumor sample requires high-throughput molecular testing. To meet this demand\, targeted next-generation sequencing (NGS) panels are useful in clinical settings for accurate tumor profiling and the identification of essential molecular aberrations for personalized therapies. By focusing only on a subset of genes\, targeted NGS is not only a cost-effective solution\, but can rapidly deliver insights into a tumor molecular profile. \nTo address this challenge\, a clinical research team led by Dr. Michela Bulfoni at the Istituto di Anatomia Patologica designed custom NGS panels\, named “Glioma” and “Routine Diagnostics”\, targeting single nucleotide variations\, insertions/deletions\, fusions\, and copy number variations of tumor-associated essential genes. \nIn this webinar\, attendees will:\nUnderstand the clinical utility of custom-designed NGS panels for accurate tumour diagnosis\nLearn about the design and application of these NGS panels\nGain insights into the cost-effectiveness and high sensitivity of NGS panels in improving sample throughput
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/benefits-of-integrating-targeted-next-generation-sequencing-ngs-panels-into-molecular-diagnostics-of-solid-tumors-2/
LOCATION:HSMD-screen-grab-2
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/08/S_1314_3_QDI_QCI_SampletoInsight_Oncology_GI1388388119-1.jpg
END:VEVENT
END:VCALENDAR